Liste der Publikationen. Prof. Dr. Volker Arolt Klinik für Psychiatrie und Psychotherapie Universitätsklinikum Münster

(1)

Liste der Publikationen

Prof. Dr. Volker Arolt

Klinik für Psychiatrie und Psychotherapie Universitätsklinikum Münster

Originalarbeiten

1. Arolt V, Bolstorff W: Ein besonderer Fall von Doppelselbstmordversuch. Nervenarzt 57 (1986) 249-251

2. Arolt V, Dilling H: Blutzellschädigungen unter der Therapie mit Neuroleptika - Drei Falldarstellungen. Psycho 13 (1987) 76-82

3. Moser A, Kömpf D, Arolt V, Resch T: Quantitative analysis of eye movements in schizophrenia. Neuro-ophthalmology 10 (1990) 73-80

4. Moser A, Kömpf D, Arolt V: Augenbewegungsstörungen bei Schizophrenen. Fokus MUL 7 (1990) 355-361

5. Arolt V, Schmidt EH: Differentielle Typologie und Psychotherapie depressiver Erkrankungen im höheren Lebensalter - Ergebnisse einer epidemiologischen Untersuchung in Nervenarztpraxen. Zeitschrift für Gerontopsychologie und -psychiatrie 5 (1992) 17-24

6. Arolt V, Dilling H: Diagnostk und Behandlung depressiver Syndrome in der Praxis niedergelassener Nervenärzte -Ergebnisse einer empirischen Untersuchung. Nervenarzt 64 (1993) 303-311

7. Delius P, Schürmann A, Schüffelgen-Daus U, Arolt V, Dilling H: Indikation psychiatrischer Konsile: Eine fallbezogene Parallelbefragung von Psychiatern und behandelnden Ärzten.

Psychiatrische Praxis 20 (1993) 218-223

8. Arolt V, Steege D, Nolte, A: Störungen der Augenbewegungen bei Schizophrenen - Kritische Übersicht und zukünftige Perspektiven. Fortschritte der Neurologie und Psychiatrie 61 (1993) 90-105

9. Arolt V: Die Einführung kriterienorientierter Klassifikationen: Probleme und Risiken in der Praxis. Krankenhauspsychiatrie 5 (1994) 21-24

10. Arolt V: Psychotherapie der Depression in den Praxen niedergelassener Nervenärzte:

Ergebnisse einer empirischen Untersuchung. Psychotherapie, Psychosomatik und medizinische Psychologie 44 (1994) 177-183

11. Arolt V, Dilling H: Confounding diagnostic systems - A major risk in the use of criteria- based manuals. Psychopathology 27 (1994) 58-63

12. Delius P, Arentewitcz G, Schürmann A, Arolt V: Weiblichen Einfühlung versus männliche Härte? Therapieempfehlungen von männlichen und weiblichen Medizinern bei Suizidpatienten. Psycho 7/8 (1994) 352-356

(2)

13. Verleger R, Bode M, Arolt V, Wascher E, Kömpf, D: Differences in P3 amplitudes between schizophrenics and healthy controls vary between the different events presented in a guessing task. Neuropsychobiology 30 (1994) 114-123

14. Delius P, Schürmann A, Arolt V, Wetterling T: Ältere Patienten im psychiatrischen Konsiliardienst. Indikationspräferenzen von behandelnden Ärzten und Ppsychiatern.

Krankenhauspsychiatrie 5 (1994) 61-65

15. Arolt V, Dilling H: Diagnostis and treatment of depressive syndromes in psychiatric office practice: findings of a survey. German Journal of Psychology 18 (1995) 60-62

16. Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H: Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophrenia Research 15 (1995) 237-242

17. Arolt V, Gehrmann A, John U, Dilling H: Psychiatrischer Konsiliardienst an einem Universitätsklinikum: Eine empirische Untersuchung zur Leistungscharakteristik.

Nervenarzt 66 (1995) 347-354

18. Arolt V, Driessen M, Schürmann A: Häufigkeit und Behandlungsbedarf von Alkoholismus bei internistischen und chirurgischen Krankenhauspatienten. Fortschritte der Neurologie, Psychiatrie 63 (1995) 283-288

19. Seidel A, Arolt V, Hunstiger M., Rink L, Behnisch A, Kirchner H: Cytokine production and serum proteins in depression. Scandinavian Journal of Immunology 41 (1995) 534-538

20. Arolt V: Die Bedeutung genetischer Faktoren für die Entstehung schizophrener Psycho- sen. Focus MUL 12 (1995) 149-156

21. Arolt V, Driessen M, Bangert-Verleger A., Neubauer H, Schürmann A, Seibert W: Psychi- sche Störungen bei internistischen und chirurgischen Krankenhauspatienten: Prävalenz und Behandlungsbedarf. Nervenarzt 66 (1995) 670-677

22. Arolt V, Wilke I, Weitzsch C, Nolte A, Pinnow M, Kirchner H: Interferon-gamma bei schizophrenen Psychosen. Focus MUL (Sonderheft Immunologie)12 (1995) 268-272

23. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V, Black- wood D, Liu X, Sjögren B, Aschauer HN, Hwu H-G, Jang K, Livesley WJ, Kennedy JL, Zoega T, Ivarsson O, Bui M-T, Yu M-H, Havsteen B, Commenges D, Weissenbach J, Schwinger E, Gottesman II, Pakstis AJ, Wetterberg L, Kidd KK, Helgason T: An international two-stage genome-wide search for schizophrenia susceptibility genes. Nature Ge- netics 11 (1995) 321-324

24. Arolt V, Lencer R, Nolte A, Pinnow M, Schwinger E: Eye tracking dysfunction in families with multiple cases of schizophrenia. European Archives of Psychiatry and Clinical Neu- rosciences 246 (1996) 175-181

25. Driessen M, Arolt V, John U, Veltrup C, Dilling H: Psychiatric comorbidity in hospitalized alcoholics after detoxification treatment. European Journal of Addiction Research 2 (1996) 17-23

26. Suslow T, Arolt V: Störungen der frühen Informationsverarbeitung und der Vigilanz als Vulnerabilitätsmarker für Schizophrenie. Fortschritte der Neurologie, Psychiatrie 64 (1996) 90-104

(3)

27. Arolt V, Driessen M: Alcoholism and psychiatric comorbidity in general hospital inpatients.General Hospital Psychiatry 18 (1996) 271-277

28. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H: Increased natural killer cells and related cytokines in major depression. Clinical Immunology and Immunopathol- ogy 78 (1996) 83-85

29. Wilke I, Arolt V, Rothermund M, Weitzsch Ch., Hornberg M, Kirchner H: Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. European Archives of Psychiatry and Clinical Neurosciences 246 (1996) 279-284

30. Arolt V, Lencer R, Nolte A, Müller-Myhsok B, Purmann S, Schürmann M, Leutelt J, Pinnow M, Schwinger E: Eye Tracking Dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. American Journal of Medical Ge- netics 67 (1996) 564-579

31. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H: Production of Cytokines in Acute Schizophrenic Psychosis. Biological Psychiatry 40 (1996) 1294-1297

32. Arolt V, Weitzsch C, Wilke I, Nolte A, Pinnow M, Rothermundt M, Kirchner H: Production of interferon- gamma in families with multiple occurrence of schizophrenia. Psychiatry Re- search 66 (1997) 145-152

33. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H: Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatrica Scandinavica 94 (1996) 198-204

34. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H: Cytokines in schizophrenia.

Response. Biol Psychiatry 41 (1997) 308-309

35. Suslow T, Arolt V: Störungen emotionaler Prozesse bei Schizophrenie - eine kognitions- psychologische Betrachtung. Zeitschrift für Psychologie 205 (1997) 119-139

36. Arolt V, Weitzsch C, Rothermundt M, Eckhoff D, Kirchner H: Interferon-gamma in schizophrenia. In:Henneberg AE, Kaschka WP (eds.): Immunological Alterations in Psy- chiatric Diseases. Advances Biological Psychiatry 18 (1997) 57-66, Karger, Basel

37. Rothermundt M, Arolt V, Levy NB: Deutsche und amerikanische Konsiliarpsychiater beur- teilen ihre Tätigkeit. Ein Beitrag zur Qualitätsverbesserung in der Konsiliarpsychiatrie.

Nervenarzt 68 (1997) 735-741

38. Suslow T, Arolt V: Paranoid schizophrenia: non-specifity of neuropsychological vulnerabil- ity markers. Psychiatry Research 72 (1997) 103-114

39. Arolt V, Driessen M, Dilling H: The Luebeck General Hospital Study I: Prevalence of psychiatric disorders in medical and surgical in-patients. International Journal of Psy- chiatry in Clinical Practice 1 (1997) 207-216

40. Suslow T, Arolt V, Junghanns K: Differentielle Validität des Fragebogens erlebter Defizite der Aufmerksamkeit (FEDA): Konkurrente Validierungsergebnisse bei schizophrenen und depressiven Patienten. Zeitschrift für klinische Psychologie, Psychopathologie und Psy- chotherapie 46 (1998) 152-165

41. Suslow T, Arolt V: Primäre und sekundäre Negativsymptome: Eine noch sinnvolle Diffe- renzierung? Nervenarzt 69 (1998) 86-88

(4)

42. Trillenberg P, Heide W, Junghanns K, Blankenburg M, Arolt V, Kömpf D: Target anticipation and impairment of smooth pursuit eye movements in schizophrenia. Experimental Brain Research 120 (1998) 316-324

43. Korte S, Arolt V, Weitzsch C, Eckhoff D, Rothermundt M, Kirchner H: Increased serum neopterin levels in acutely ill and remitted schizophrenic patients. Schizophrenia Re- search 32 (1998) 63-67

44. Suslow T, Junghanns K, Weitzsch C, Arolt V: Relations between neuropsychological vul- nerability markers and clinical symptoms in schizophrenic patients. Psychopathology 31 (1998) 178-187

45. Suslow T, Arolt V, Junghanns K: Alexithymie und automatische Aktivierung emotional- evaluativer Informationen. Psychotherapie, Psychosomatik und medizinische Psychologie 48 (1998)168-175.

46. Suslow T, Arolt V: Effektivität eines computergestützten Aufmerksamkeitstrainings bei schizophrenen Patienten. Psychiatrische Praxis 25 (1998) 105-110

47. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H: Immunological Dysfunction in schizophrenia. A systematic approach. Neuropsychobiologie 37 (1998) 186-193

48. Arolt V, Fein A, Driessen M, Dorlöchter L, Maintz C.: Depression and social Functioning in general hospital in-patients. Journal of Psychosomatic Research 42 (1998) 117-126

49. Suslow T, Arolt V: Backward masking in schizophrenia: time course of visual processing deficits during task performance. Schizophrenia Research 33 (1998) 79-86

50. Arolt V, Teichert HM, Steege D, Lencer R, Heide W: Distinguishing schizophrenic patients from healthy controls by quantitative measurement of eye movement parameters.

Biological Psychiatry 15 (1998) 448-58

51. Suslow T, Arolt V: Die Erfassung negativer Schizotypie: Schamangst anstatt flacher Affekt? Psychologische Beiträge 40 (1998) 171-185

52. Suslow T, Arolt V, Junghanns K: Differentielle Validität des Fragebogens erlebter Defizite der Aufmerksamkeit (FEDA): konkurrente Validierungsergebnisse bei schizophrenen und depressiven Patienten. Psychotherapie, Psychosomatik und medizinische Psychologie 46 (1998)152-165

53. Suslow T, Weber A, Wellnitz C, Arolt V: Computergestütztes kognitives Training für schi- zophrene Patienten: Positionsbestimmung und Gestaltungsvorschläge. Zeitschrift für Er- gotherapie 4 (1998), 253-258

54. Lencer R, Malchow CP, Krecker K, Nolte A, Pinnow M, v Siefart SZ, Schwinger E, Arolt V: Smooth pursuit performance in families with multiple occurrence of schizophrenia and nonpsychotic families. Biological Psychiatry 45 (1999) 694-703

55. Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, Kirchner H: Elevated plasma levels of S-100b protein in schizophrenic patients. Biological Psy- chiatry 45 (1999) 1508-1511

56. Verleger R, Wascher E, Arolt V, Daase C, Strohm A, Kompf D: Slow EEG potentials (contingent negative variation and post-imperative negative variation) in schizophrenia:

(5)

their association to the present state and to Parkinsonian medication effects. Clin Neurophysiol 110 (1999) 1175-92

57. Meissner B, Purmann S, Schurmann M, Zuhlke C, Lencer R, Arolt V, Muller-Myhsok B, Morris-Rosendahl DJ, Schwinger E: hSKCa3: a candidate gene for schizophrenia?

Psychiatr Genet 9 (1999) 91-96

58. Nolte A, Moser A, Kömpf D, Arolt V: The effect of distraction on smooth pursuit eye movements - comparison of normal subjects with schizophrenic patients. Neuro- ophtalmology 21 (1999) 147-155

59. Arolt V, Lencer R, Purmann S, Schurmann M, Muller-Myhsok B, Krecker K, Schwinger E: Testing for linkage of eye tracking dysfunction and schizophrenia to markers on chromosomes 6, 8, 9, 20, and 22 in families multiply affected with schizophrenia. Am J Med Genet 88 (1999) 603-606

60. Suslow T, Arolt V, Marano GF, Battacchi MW, Hönow M: Zur Reliabilität und Validität einer deutschsprachigen Version der Scham-Schuld-Skala. Psychologische Beiträge, Band 41 (1999) 439-457

61. Lencer R, Malchow CP, Trillenberg-Krecker K, Schwinger E, Arolt V: Eye Tracking Dysfunction (ETD) in families with sporadic and familial schizophrenia. Biological Psy- chiatry 47 (2000) 391-401

62. Kersting A, Arolt V: Psychosomatische Störungen bei Müttern. Historische Hintergrün- de, Erkrankungsursachen und psychotherapeutische Behandlungskonzepte. Psycho- therapeut 45 (2000) 10-17

63. Arolt V, Rothermundt M, Wandinger KP, Kirchner H: Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. Molecular Psychiatry 5 (2000) 150-158

64. Erfurth A, Michael N, Mostert C, Arolt V: Euphoric Mania and Rapid Transcranial Mag- netic Stimulation. American Journal of Psychiatry 157 (2000) 835-836

65. Höping W, Folkerts H, deJong-Meyer R, Arolt V: Kognitive Beeinträchtigungen depressiver Patienten bei automatischer vs. kontrollierter Informationsverarbeitung. Zeitschrift für Klinische Psychologie, Psychiatrie und Psychotherapie 48 (2000) 234-244

66. Kersting A, Arolt V: Unterschiedliche Therapieziele von Patient und Therapeut in der stationären Psychotherapie. Psychotherapeut 45 (2000) 247-248

67. Stadtland C, Erfurth A, Arolt V: De Novo Onset of Parkinson’s Disease After Antide- pressant Treatment With Citalopram. Pharmacopsychiatry 33 (2000) 194-195

68. Engelien A, Schulz M, Ross B, Arolt V, Pantev C: A combined functional in vivo meas- ure for primary and secondary auditory cortices. Hearing Research 148 (2000) 153-160

69. Rothermundt M, Arolt V, Leadbeater J, Peters M, Rudolf S, Kirchner H: Cytokine production in unmedicated and treated schizophrenic patients. NeuroReport 11 (2000), 3385-3388

70. Suslow T, Donges U-S, Kersting A, Arolt V: 20-Items Toronto Alexithymia Scale: Do difficulties describing feelings assess proneness to shame instead of difficulties sym- bolizing emotions? Scandinavian Journal of Psychology 41 (2000), 329-334

(6)

71. Pecuch PW, Evers S, Folkerts HW, Michael N, Arolt V: The cerebral hemodynamics of repetitive transcranial magnetic stimulation. Eur Arch Psychiatry Clin Neurosci 250 (2000): 320-324

72. Rothermundt M, Arolt V, Peters M, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H: Inflammatory markers in major depression and melancholia. Journal of Affective Disorders 63 (2001) 93-102

73. Suslow T, Ohrmann P, Arolt V: Ausgestaltung sogenannter affektiver Voraktivierungs- effekte in der evaluativen Entscheidungsaufgabe: Hinweise auf automatische Vigilanz für negative Informationen. Z Psychol 209 (2001) 137-152

74. de Jonge P, Huyse FJ, Slaets JP, Herzog T, Lobo A, Lyons JS, Opmeer BC, Stein B, Arolt V, Balogh N, Cardoso G, Fink P, Rigatelli M, van Dijck R, Mellenbergh GJ: Care complexity in the general hospital: results from a european study. Psychosomatics 42 (2001) 204-212

75. de Jonge P, Huyse FJ, Herzog T, Lobo A, Slaets JP, Lyons JS, Opmeer BC, Stein B, Arolt V, Balogh N, Cardoso G, Fink P, Rigatelli M: Risk factors for complex care needs in general medical inpatients: results from a european study. Psychosomatics 42 (2001) 213-221

76. Huyse FJ, de Jonge P, Slaets JP, Herzog T, Lobo A, Lyons JS, Opmeer BC, Stein B, Arolt V, Balogh N, Cardoso G, Fink P, Rigatelli M: Compri – an instrument to detect patients with complex care needs: results from a european study. Psychosomatics 42 (2001) 222-228

77. Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H: Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci (2001) 251: 90-97

78. Suslow T, Kersting A, Ohrmann P, Arolt V: Eine Kritik des Konstruktes „Alexithymie“

und seiner Erfassung – Von der Schwäche der Selbstbeschreibung und den Möglich- keiten eines objektiven Untersuchungsansatzes. Z psychosom Med Psychother 47 (2001) 153-166

79. Suslow T, Junghanns K, Arolt V: Detection of facial expressions of emotions in depression. Perceptual and Motor Skills (2001) 92: 857-868

80. Rothermundt M, Arolt V, Wiesmann M, Missler U, Peters M, Rudolf S, Kirchner H:

S-100B is increased in melancholic but not in non-melancholic major depression. Jour- nal of Affectice Disorders (2001) 66: 89-93

81. Arolt V: Herzpatient mit depressiver Störung. So behandeln Sie richtig. MMW Fort- schritte der Medizin 143 (2001); 745-748

82. Feldmann R, Hornung WP, Buchkremer G, Arolt V: The Influence of Familial Loading on the Course of Schizophrenic Symptoms and the Success of Psychoeducational Therapy. Psychopathology (2001) 34: 192-197

83. De Jonge P, Zomerdijk MM, Huyse FJ, Fink P, Herzog T, Lobo A, Slaets JPJ, Arolt V, Balogh N, Cardoso G, Rigatelli M: Mental disturbances and perceived complexity of nursing care in medical inpatients: results from a European study. Journal of Advanced Nursing (2001) 36 (3), 355-363

(7)

84. Rothermundt M, Missler U, Arolt V, Peters M, Leadbeater J, Wiesmann M, Rudolf S, Wandinger KP, Kirchner H: Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Molecular Psychiatry (2001) 6, 445-449

85. Kersting A, Reutemann M, Ohrmann P, Schütt K, Wesselmann U, Rothermundt M, Suslow T, Arolt V: Traumatische Trauer – ein eigenständiges Krankheitsbild? Psycho- therapeut (2001) 46: 301-308

86. Suslow T, Junghanns K, Donges US, Arolt V: Alexithymia and automatic processing of verbal and facial affect stimuli. Cahiers de Psychologie Cognitive/Current Psychology of Cognition (2001) 20, 5: 297-324

87. Schonauer K, Klar M, Kehrer HE, Arolt V: Lebenswege frühkindlicher Autisten im Er- wachsenenalter. Fortschr Neurol Psychiat (2001) 69, 221-235

88. Rothermundt M, Arolt V, Bayer TA: Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun (2001) 15, 319-339

89. Erfurth A, Michael N, Stadtland C, Arolt V: Bupropion as Add-On Strategy in Difficult-to -Treat Bipolar Depressive Patients. Neuropsychobiology (2002) 45, 33-36

90. Kersting A, Arolt V: Das Gespräch mit Angehörigen nach dem Suizid einer Patientin.

Psychotherapeut (2002) 47, 106-108

91. Feldmann R, Hornung WP, Prein B, Buchkremer G, Arolt V: Timing of

psychoeducational psychotherapeutic interventions in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci (2002) 252, 115-119

92. Kersting A, Reutemann M, Staats H, Ohrmann P, Suslow T, Arolt V: Wirkfaktoren am- bulanter Gruppentherapie. Psychother Psych Med (2002) 52, 294-301

93. Arolt V: Begleitung des depressiven Patienten in der Hausarztpraxis. MMW-Fortschr Med 144 (2002) 706-709

94. Arolt V, Rothermundt M, Peters M, Leonard B: Immunological research in clinical psychiatry: report on the consensus debate during the 7^th expert meeting on psychiatry and immunology. Molecular Psychiatry (2002) 7, 822-826

95. Svensson B, Peters M, König HG, Poppe M, Levkau B, Rothermundt M, Arolt V, Kögel D, Prehn JHM: Vascular Endothelial Growth Factor Protects Cultured Rat Hippocampal Neurons Against Hypoxic Injury via an Antiexcitotoxic, Caspase-Independent Mechism.

Journal of Cerebral Blood Flow & Metabolism 22 (2002) 1170-1175

96. Lencer R, Trillenberg-Krecker K, Schwinger E, Arolt V: Schizophrenia spectrum disorders and eye tracking dysfunction in singleton and multiplex schizophrenia families.

Schizophr Res 60 (2003) 33-45

97. Rudolf S, Peters M, Rothermundt M, Arolt V, Kirchner H: The Influence of Typical and Atypical Neuroleptic Drugs in the Production of Interleukin-2 and Interferon-Gamma in vitro. Neuropsychobiology 46 (2002) 180-185

98. Michael N, Sourgens H, Arolt V, Erfurth A: Severe Tardive Dyskinesia in Affective Dis- orders: Treatment with Vitamin E and C. Neuropsychobiology 46 (suppl 1) (2002) 28- 30

(8)

99. Domschke K, Kuhlenbäumer G, Schirmacher A, Lorenzi C, Armengol L, DiBella D, Gratacos M, Garritsen HS, Nöthen MM, Franke P, Sand P, Fritze J, Perez G, Maier W, Sibrowski W, Estivill Y, Bellodi L, Ringelstein EB, Arolt V, Martin-Santos M, Catalano M, Stögbauer F, Deckert J: Human Nuclear Transcription Factor Gene CREM: Geno- moc Organization, Mutation Screening, and Association Analysis in Panic Disorder.

American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 117B (2003) 70-8

100. Erfurth A, Arolt V: Das Spektrum bipolarer Erkrankungen. Nervenarzt 74 (2003) 55-71

101. Möller O, Hetzel G, Rothermundt M, Michael N, Nyhuis PW, Suslow Th, Arolt V, Erfurth A: Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment. Journal of Psychiatric Research 37 (2003) 261-262

102. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B: Neurotrophic Ef- fects of Electroconvulsive Therapy: A Proton Magnetic Resonance Study of the Left Amygdalar Region in Patients with Treatment-Resistant Depression.

Neuropsychopharmacology 28 (2003) 720-725

103. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, Fiebich M, Arolt V, Heindel W: Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psych Res:

Neuroimag 122 (2003) 185 – 192

104. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, Kirchner H, Rother- mundt M: S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacology 13 (2003) 235-239

105. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B: Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychological Medicine 33 (2003) 1277-1284

106. Michael N, Erfurth, A, Ohrmann P, Gösling M, Arolt, V, Heindel W, Pfleiderer B: Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 168 (2003) 344-346

107. Kersting A, Reutemann M, Gast U, Ohrmann P, Suslow T, Michael N, Arolt V:

Dissociative Disorders and Traumatic Childhood Experiences in Transsexuals. J Nerv Ment Dis 191 (2003), 182-189

108. Rothermundt M, Peters M, Prehn JHM, Arolt V: S 100B in Brain Damage and Neuro- degeneration. Micros Res Tech 60 (2003) 614-632

109. Kersting A, Fisch S, Arolt V: Outpatient psychotherapy for mothers – a new treatment.

Arch Womens Ment Health 6 (2003) 65-69

110. Michael N, Gösling M, Reutemann M, Kersting A, Heindel W, Arolt V, Pfleiderer B:

Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (¹ H MRS) study of healthy brain. European Journal of Neuroscience 17 (2003), 2462-2468

111. Suslow T, Roestel C, Ohrmann P, Arolt V: The experience of basic emotions in schizophrenia with and without affective negative symptoms. Compr Psychiatry 44 (4) (2003), 303-310

(9)

112. Suslow, Roestel C, Droste T, Arolt V: Automatic processing of verbal emotion stimuli in schizophrenia. Psychiatry Research 120 (2003), 131-144

113. Suslow T, Roestel C, Ohrmann P, Arolt V: Detection of facial expressions of emotions in schizophrenia. Schizophrenia Research 64 (2003), 137-145

114. Suslow T, Kersting A, Arolt V: Alexithymia and Incidental Learning of emotional words.

Psychological Reports 93 (2003), 1003-1012

115. Kersting A, Fisch S, Suslow T, Ohrmann P, Arolt V: Messinstrumente zur Erfassung von Trauer – Ein kritischer Überblick. Psychother Psych Med 53 (2003), 475-484

116. Suslow T, Roestel C, Arolt V: Affective priming in schizophrenia with and without affective negative symptoms. Eur Arch Psychiatry Clin Neurosci 253 (2003) 292-300

117. Kersting A, Kuschel S, Reutemann M, Ohrmann P, Arolt V: Outpatient Psychotherapy for Mothers – First Empirical Resuls. Psychiatry 66 (2003), 335-345

118. Dietrich DE, Hauser U, Peters M, Zhang Y, Wiesmann M, Hasselmann M, Rudolf S, Jüngling O, Kirchner H, Münte TF, Arolt V, Emrich HM, Johannes S, Rothermundt M:

Target evaluation processing and serum levels of nerve tissue protein S 100 B in patients with remitted major depression. Neuroscience Letters 354 (2004), 69-73

119. Ohrmann P, Kersting A, Suslow T, Lalee-Mentzel J, Donges U, Fiebich M, Arolt V, Heindel W, Pfleiderer B: Proton magnetic resonance spectroscopy in anorexia nervosa:

correlations with cognition. NeuroReport 15 (2004) 549-553

120. Rothermundt M, Ponath G, Glaser T, Hetzel G, Arolt V: S100B Serum Levels and Long-Term Improvment of Negative Symptoms in Patients with Schizophrenia.

Neuropsychopharmacology 29 (2004) 1004-1011

121. Rudolf S, Schlenke P, Broocks A, Peters M, Rothermundt M, Arolt V: Search for atypical lymphocytes in schizophrenia. World J Biol Psychiatry 1 (2004) 33-37

122. Rothermundt M, Falkai P, Ponath G, Abel S, Burkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V: Glial cell dysfunction in schizophrenia indicated by increased S 100 B in the CSF. Mol Psychiatry (2004) 1-2

123. Fink P, Ornbol E, Huyse FJ, de Jonge P, Lobo A, Herzog T, Slaets J, Arolt V, Cardoso G, Rigatelli M, Hansen MS: A brief diagnostic screening instrument for mental distur- bance in general medical wards. J Psychosom Research 57 (2004) 17-24

124. Lencer R, Trillenberg P, Trillenberg-Krecker K, Junghanns K, Kordon A, Broocks A, Hohagen F, Heide W, Arolt V: Smooth pursuit deficits in schizophrenia, affective disorder and obsessive-compulsive disorder. Psychological Medicine 34 (2004) 451-460

125. Kögel D, Peters M, König H-G, Hasehemi SMA, Bui NT, Arolt, V, Rothermundt M, Prehn JHM: S100B Potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications fort he role of S100B excitotoxic brain injury.

Neuroscience 127 (2004) 913-920

126. Arolt V, Michael N: Wenn der Spaßvogel Gefahr signalisiert… MMW-Fortschr Med 38 (2004) 766-769

(10)

127. Hetzel G, Moeller O, Erfurth A, Michael N, Rothermundt M, Arolt V, Evers S: The Im- pact of the Selective Monoamine Reuptake Inhibitors Reboxetine and Citralopram on Visually-Evoked Event-Related Potentials in Depressed Patients. Pharmacopsychiatry 37 (2004) 200-205

128. Suslow T, Dannlowski U, Lalee-Mentzel J, Donges US, Arolt V, Kersting A: Spatial processing of facial emotion in patients with unipolar depression: a longitudinal study.

Journal of Affective Disorders 83 (2004) 59-63

129. Kersting A, Dorsch M, Wesselmann U, Lüdorff K, Witthaupt J, Ohrmann P, Hörning- Franz I, Klockenbusch W, Harms E, Arolt V: Maternal posttraumatic stress response after the birth of a very low-birth-weight infant. J Psychosom Research 57 (2004) 473- 476

130. Kersting A, Reutemann M, Ohrmann P, Baez W, Klockenbusch W, Lanczik M, Arolt V:

Grief after termination of pregnancy due to fetal malformation. J Psychosom Obstet Gynecol 25 (2004) 163-169

131. Suslow, T, Ohrmann P, Lalee-Mentzel J, Donges US, Arolt V, Kersting A: Incidental learning of food and emotional words in women with anorexia nervosa. Eating Weight Disord 9 (2004) 290-295

132. Arolt V, Rothermundt M: Psychische Erkrankungen und Immunsystem. Psychother Psych Med Psychol 55 (2005) 36-48

133. Ohrmann P, Siegmund A, Suslow Th, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B: Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophrenia Research 73 (2005) 153-157

134. Moeller O, Hetzel G, Michael N, Rothermundt M, Arolt V, Erfurth A: Basal Prolactin Values Correlate with Response to Reboxetine Treatment in Major Depression, but Not with Response to Citalopram. Neuropsychobiology 51 (2005) 67-71

135. Kersting A, Dorsch M, Kreulich C, Reutemann M, Ohrmann P, Baez E, Arolt V: Trauma and grief 2-7 years after termination of pregnancy because of fetal anomalies – a pilot study. Journal of Psychosomatic Obstetrics & Gynaecology 26 (2005), 9-14

136. Donges US, Kersting A, Dannlowski U, Lalee-Mentzel J, Arolt V, Suslow Th: Reduced Awareness of Others’ Emotions in Unipolar Depressed Patients. J Nerv Ment Dis 193 (2005) 331-337

137. Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, Rothermundt M. The astro- glial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology 178 (2005) 161-166

138. Baune BT, Arolt V: Psychiatrische Epidemiologie und Bevölkerungsmedizin. Prinzipien der Versorgungsforschung. Der Nervenarzt 76 (2005) 633-646

139. Kästner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, Rothermundt M: Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis acticity. J Afffective Disorders 87 (2005) 305-311

(11)

140. Kölkebeck K, Ohrmann P, Hetzel G, Arolt V, Suslow T: Visual backward masking: deficits in locating targets are specific to schizophrenia and not related to intellectual de- cline. Schizophr Res 78 (2005) 261-268

141. Suslow T, Droste T, Roestel C, Arolt V: Automatic processing of facial emotion in schizophrenia with and without affective negative symptoms. Cognit Neuropsychiatry 10 (2005), 35-56

142. Dannlowski U, Kersting A, Donges US, Lalee-Mentzel J, Arolt V, Suslow T: Masked facial affect priming is associated with therapy response in clinical depression. Eur Arch Psychiatry Clin Neurosci 256 (2006), 215-221

143. Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J: Association of the functional (minus

sign)1019C/G 5 HT 1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 9 (2006) 349- 355

144. Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, Spell- mann I, Hetzel G, Maino K, Kleindienst N, Möller H-J, Arolt V, Riedel M: The cyclooxy- genase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecu- lar Psychiatry 11 (2006), 680-684

145. Suslow T, Ohrmann P, Bauer J, Rauch AV, Schwindt W, Arolt V, Heindel W, Kugel H:

Amygdala activation during masked presentation of emotional faces predicts conscious detection of threat-related faces. Brain Cogn 61 (2006), 243-248

146. Dannlowski U, Kersting A, Arolt V, Lalee-Metzel J, Donges US, Suslow T: Unimpaired automatic processing of verbal information in the course of clinical depression. Depress Anxiety 23 (2006), 325-330

147. Spengler D, Trillenberg P, Sprenger A, Nagel M, Kordon A, Junghanns K, Heide W, Arolt V, Hohagen F, Lencer R: Evidence from increased anticipation of predictive sac- cades for a dysfunction of fronto-striatal circuits in obsessive-compulsive disorder. Psy- chiatry Research 143 (2006), 77-88

148. Baune BT, Suslow T, Engelien A, Arolt V, Berger K: The Association between Depres- sive Mood and Cognitive Performance in an Elderly General Population – The MEMO Study. Dement Geriatr Cogn Disord 22 (2006) 142-149

149. Arolt V: Die (Neu-)Definition von Compliance. Krankenpfl J. 43 (2005) 214-215

150. Domschke KE, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C, Kersting A,

Engelien A, Arolt V, Heindel W, Kugel H. Deckert J: The catechol-O-methyltransferase val158met genotype influences processing of emotional stimuli in panic Disorder. Biol Psychiat 59 (2006), 143

151. Dannlowski U, Kersting A, Lalee-Mentzel J, Donges US, Arolt V, Suslow T: Subliminal affective priming in clinical depression and comorbid anxiety: A longitudinal investiga- tion. Psychiatry Res 143 (2006), 63-75

152. Baune BT, Adrian I, Arolt V, Berger K: Association between Major Depression, Bipolar Disorders, Dysthymia and Cardiovascular Diseases in the General Adult Population.

Psychother Psychosom 75 (2006) 319-326

(12)

153. Hihn H, Baune BT, Michael N, Markowitsch H, Arolt V, Pfleiderer B: Memory Perform- ance in Severely Depressed Patients Treated by Electroconvulsive Therapy. J ECT 22 (2006), 189-195

154. Schilling M, Brückner-Totonji C, Arolt V, Baune BT: A case of multiple sclerosis

masked by depression and diabetic neurophathy. Psychosomatics 47 (2006), 361-363

155. Baune BT, Suslow T, Arolt V, Berger K: The relationship between psychological di- mensions of depressive symptoms and cognitive functioning in the elderly – The MEMO-Study. J Psychiatric Research 41 (2007), 247-254

156. Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rother- mundt M, Arolt V, Heindel W, Pfleiderer B: Cognitive impairment and in vivo metabo- lites in first-episode neuroleptic-naïve and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study. J of Psychiatric Research 41 (2007) 625-634

157. Rothermundt M, Ohrmann P, Abel S, Siegmund A, Pedersen A, Ponath G, Suslow T, Peters M, Kaestner F, Heindel W, Arolt V, Pfleiderer B: Glial cell activation in a sub- group of patients with schizophrenia indicated by increased S 100B serum concentrations and elevated myoinositol. Prog Neuropsychopharmakol Biol Psychiatry 31 (2007) 361-364

158. Dannlowski U, Ohrmann P, Bauer J, Kugel H, Arolt V, Heindel W, Suslow T: Amygdala reactivity predicts automatic negative evaluations for facial emotions. Psychiatry Re- search: Neuroimaging 154 (2007), 13-20

159. Rauch AV, Ohrmann P, Bauer J, Kugel H, Engelien A, Arolt V, Heidel W, Suslow T:

Cognitive Coping Style Modulations Neural Response to Emotional Faces in Healthy Humans: A 3-T fMRI Study. Cerebral Cortex 17 (2007) 2526-2535

160. Ponath G, Schettler C, Kaestner F, Voigt V, Wentker D, Arolt V, Rothermundt M:

Autocrine S 100B effects on astrocytes are mediated via RAGE. J Neuroimmunol 184 (2007), 214-222

161. Dannlowski U, Ohrmann P, Bauer J, Kugel H, Baune BT, Hohoff C, Kersting A, Arolt V, Heindel W, Deckert J, Suslow T: Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav 7 (2007) 672-676

162. Ohrmann P, Rauch AV, Bauer J, Kugel H, Arolt V, Heindel W, Suslow T.Threat sensitivity as assessed by automatic response to fearful faces predicts speed of visual search for facial expression. Exp Brain Res 183 (2007), 51-59

163. Moeller O, Evers S, Deckert J, Baune BT, Dannlowski U, Nguyen DH, Arolt V, Hetzel G: The impact of ziprasidone in combination with sertraline on visually-evoked event- related potentials in depressed patients with psychotic features. Prog Neuropsycho- pharmacol Biol Psychiatry 31 (2007), 1440-1443

164. Schöning S, Engelien A, Kugel H, Schäfer S, Schiffbauer H, Zwitserlood P, Pletziger E, Beizai P, Kersting A, Ohrmann P, Greb RR; Lehmann W, Heindel W, Arolt V, Konrad C: Functional anatomy of visuo-spatial working memory during mental rotation is influenced by sex, menstrual cycle, and sex steroid hormones. Neuropsychologia 45 (2007) 3203-3214

(13)

165. Kästner F, Mosert C, Behnken A, Böckermann I, Ternes F, Diedrich M, Zavorotnyy M, Arolt V, Weckesser M, Rothermundt M. Therapeutic strategies for catatonia in para- neoplastic encephalitis. World J Biol Psychiatry 12 (2007), 1-5

166. Pfleiderer B, Zinkiciran S, Arolt V, Heindel W, Deckert J, Domschke K. fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World J Biol Psychiatry 8 (2007) 269-272

167. Dannlowski U, Ohrmann P, Bauer J, Kugel H, Arolt V, Heindel W, Kersting A, Baune BT, Suslow T. Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study. J Psychiatry Neurosci 32 (2007), 423-429

168. Zwanzger P, Eser D, Rupprecht R: Antieleptika in der Therapie von Angsterkrankun- gen – eine mögliche therapeutische Alternative? Nervenarzt 78 (2007), 1274-1282

169. Kersting A, Kroker K, Steinhard J, Lüdorff K, Wesselmann U, Ohrmann P, Arolt V, Sus- low T: Complicated grief after traumatic loss: A 14-month follow up study. Eur Arch Psychiatry Clin Neurosci 257 (2007), 437-443

170. Baune BT, Hohoff C, Mortensen LS, Deckert J, Arolt V, Domschke K. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depress Anxiety 25 (2007) 920-925

171. Kersting A, Kroker K, Horstmann J, Baune BT, Hohoff C, Mortensen LS, Neumann LC, Arolt V, Domschke K: Association of MAO-A Variant with Complited Grief in Major De- pression. Neuropsychobiology 56 (2007), 191-196

172. Dannlowski U, Ohrmann P, Deckert J, Hohoff C, Kugel H, Arolt V, Heindel W, Kersting A, Baune BT, Suslow T: 5-HTTLPR Biases Amygdala Activity in Response to Masked Facial Expressions in Major Depression. Neuropsychopharmacology 33 (2008), 418- 424

173. Baune BT, Ponath G, Golledge J, Varga G, Arolt V, Rothermundt M, Berger K: Asso- ciation between IL-8 cytokine and cognitive performance in an elderly general population- The MEMO-Study. Neurobiol Aging 29 (2008) 937-944

174. Baune BT, Hohoff C, Berger K, Neumann A, Mortensen S, Roehrs T, Deckert J, Arolt V, Domschke K: Association of the COMT val l 158met Variant with Antidepressant Treatment Response in Major Depression. Neuropsychopharmacology 33 (2008), 924- 932

175. Pedersen A, Siegmund A, Ohrmann P, Rist F, Rothermundt M, Suslow T, Arolt V. Re- duced implicit and explicit sequence learning in first-episode schizophrenia. Neuropsy- chologia 46 (2008) 186-195

176. Domschke K, Hohoff C, Mortensen LS, Roehrs T, Deckert J, Arolt V, Baune BT. Mono- amine oxidase A variant influences antidepressant tretment response in female patients with Major Depression. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008), 224-228

177. Domschke K, Hohoff C, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Käst- ner F, Rothermundt M, Arolt V, Deckert J. Chromosome 4q31-34 panic disorder risk locus: Association of neuropeptide Y Y5 receptor variants. Am J Med Genet Part B (Neuropsychiatr Genetic) 147 B, (2008) 510-516

(14)

178. Koelkebeck K, Ohrmann P, Pedersen A, Hetzel G, Arolt V, Suslow T. Finding of ab- normal scanning behaviour in the Span of Apprehesion task in schizophrenia but diagnostic nun-specificity of sums scores. Eur Psychiatry 23 (2008), 29-32

179. Kugel H, Eichmann M, Dannlowski U, Ohrmann P, Bauer J, Arolt V, Heindel W, Suslow T: Alexithymic features and automatic amygdale reactivity to facial em. Neurosci Lett 435 (2008), 40-44

180. Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J, Kugel H: Inflluence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Research Neuroimaging 163 (2008), 13-20

181. Baune BT, Hohoff C, Roehrs T, Deckert J, Arolt V, Domschke K: Serotonin receptor 1A-1019C/G variant: Impact on antidepressant pharmacoresponse in melanchonic depression Neurosci Lett 436 (2008 ) 111-115

182. Baune BT, Wiede F, Braun A, Golledge J, Arolt V, Koerner H: Cognitive dysfunction in mice deficient for TNF –and its receptors. Am J Med Genet B Neuropsychiatr Genet 147 B (2008) 1056-1064

183. Dannlowski U, Baune BT, Böckermann I, Domschke K, Evers S, Arolt V, Hetzel G, Rothermundt M: Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects reduction, psychopathology and remission rates. Hum Psy- chopharmacol Clin Exp 23 (2008) 587-593

184. Domschke K, Dannlowski U, Ohrmann P, Lawford B, Bauer J, Kugel H, Heindel W, Young R, Morris P, Arolt V, Deckert J, Suslow T, Baune BT: Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. Eur Neuropsychopharmacol 18 (2008) 751-759

185. Arolt V: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. Wachsendes Wissen erfordert neue therapeutische Möglichkeiten. Nervenarzt 79 (2008) 769-770

186. Konrad C, Engelien A, Schöning S, Zwitserlood P, Jansen A, Pletziger E, Beizai P, Kersting A, Ohrmann P, Luders E, Greb RR, Heindel W, Arolt V, Kugel H: The functional anatomy of semantic retrieval is influenced by gender, menstrual cycle, and J Neural Transm 115 (2008) 1327-1337

187. Pedersen A, Diedrich M, Kästner F, Kölkebeck K, Ohrmann P, Ponat G, Kipp F, Abel S, Siegmund A, Suslow T, von Eiff C, Arolt V, Rothermundt M: Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1789-1792

188. Ohrmann P, Kugel H, Bauer J, Siegmund A, Kölkebeck K, Suslow T, Wiedl KH,

Rothermundt M, Arolt V, Pedersen A: Learning potential on the WCST in schizophrenia is related to the neuronl integrity of the anterior cingulated cortex as measured by proton magnetic resonance spectroscopy. Schizophr Res 106 (2008) 156-163

189. Suslow T, Arolt V:: Schizophrenia-like-personality disorders. Nervenarzt 80 (2009), 343-350

190. Kölkebeck K, Domschke K, Zwanzger P, Hetzel G, Lang D, Arolt V. A case of non- SIADH-induced hyponatremia in depression after treatment with reboxine. World J Biol Psychiatry 10 (2009), 609-611

(15)

191. Domschke K, Deckert J, Arolt V, Baune B: Anxious versus non-anxious depression:

difference in treatment outcome. J Psychopharmacol (2008) im Druck

192. Hohoff C, Neumann A, Domschke K, Jakob C, Maier W, Fritze J, Bandelow B, Krako- witzky P, Rothermundt M, Arolt V, Deckert J: Association analysis of Rgs7 variants with panic disorder. J Neural Transm 116 (2009), 1523-1528

193. Dannlowski U, Ohrmann P, Konrad C, Domschke K, Bauer J, Kugel H, Hohoff C, Schöning S, Kersting A, Baune BT, Mortensen LS, Arolt V, Zwitserlood P, Deckert J, Heindel W, Suslow T: Reduced amygdala-prefrontal coupling in major depression: association with MAOA genot severity. Int J Neuropsychopharmacol 12 (2009) 11-22

194. Schöning S, Zwitserlood P, Engelien A, Behnken A, Kugel H, Schiffbauer H, Lipina K, Pachur C, Kersting A, Dannlowski U, Baune BT, Zwanzger P, Reker T, Heindel H, Arolt V, Konrad C: Working-Memory fMRI Reveals Cingulate Hyperactivation in Euthymic Major Depression. Human Brain Mapping 30 (2009), 2746-2756

195. Sullivan PF, de Geus EJ, Willemsen G, James RM, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Chichon S, Coventry WL, Domschke K, Farmer A, Fava M, Gordon SD, He Q, Heath AC, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hu Y, Kohli M, Lin D, Lucae S, Macintyre DJ, Maier W, McGhee KA, McGuffin P, Montgomery GW, Muir WJ, Nolen WA, Nöthen MM, Perlis RH, Pirlo K, Posthuma D, Rietschel M, Rizzu P, Schosser A, Smit AB, Smoller JW, Tzeng JY, van Dyck R, Verhage M, Zitman FG, Martin NG, Wray NR, Boomsma DI, Penninx BW: Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 14 (4) 2009, 359-375

196. Kersting A, Kroker K, Steinhard J, Hoernig-Franz I, Wesselmann U, Luedorff K, Ohr- mann P, Arolt V, Suslow T: Psychological impact on woman after second and third trisemester termination of pregnancy due to fetal anomalies versus woman after pre- term birth-a 14-month follow up study. Arch Womans Ment Health 12 (4) (2009) 193- 201

197. Kersting A, Kroker K, Horstmann J, Ohrmann P, Baune BT, Arolt V, Suslow T: Compli- cated grief in patients with unipolar depression. J Affect Disord 118 (2009) 201-204

198. Baune BT, Caniato RN, Arolt V, Berger K: The Effects of Dysthmyic Disorder on Health-Related Quality of Life and Disability Days in Person with Comorbid Medical Conditions in the General Population. Psychother Psychosom 78 (3), 2009, 161-166

199. Domschke K, Zavorotnyy M; Diemer J, Nitsche S, Hohoff C, Baune BT, Deckert J, Arolt V, Zwanzger P: COMT val158met influence on electroconvulsive therapy response in major depression. Am J Med Genet B Neuropsychiatr Genet 153 B (2009) 286-290

200. Suslow T, Kugel H, Rauch AV, Dannlowski U, Bauer J, Konrad C, Arolt V, Heindel W, Ohrmann P: Attachment avoidance modulates neural response to masked facial emotion. Hum Brain Mapp 11 (2009) 3553-3562

201. Arolt V, Zwanzger P, Ströhle A, Hamm A, Gerlach A, Kircher T, Deckert J: The research network PANIC-NET: improving the treatment of panic disorder – from a better understanding of fear circuit mechanism to more effective psychological treatment and routine care. Psychother Psychosom Med Psychol 59/3-4, 124-131 (2009)

202. Zhang Y, Rothermundt M, Peters M, Wiesmann M, Hoy L, Arolt V, Emrich HM, Dietrich DE: S100B Serum Levels and Word Memory Processing in Remitted Major Depression as Reflected by Brain Potentials. Neuropsychobiology 59 (3) (2009) 172-177

(16)

203. Konrad C, Ukas T, Nebel C, Arolt V, Toga AW, Narr KL, Defining the human hippo- campus in cerebral magnetic resonance images – An overview of current segmenta- tions protocols. Neuroimage 47 (2009), 1185-1195

204. Pedersen A, Küppers K, Behnken A, Kroker K, Schöning S, Baune BT, Rist F, Arolt V, Suslow T: Implicit and explicit procedual learning in patients recently remitted from severe major depression. Psychiatry Res 169 (2009), 1-6

205. Sehlmeyer C, Schöning S, Zwitserlood P, Pfleiderer B, Kircher T, Arolt V, Konrad C:

Human fear conditioning and extinction in neuroimaging: a systematic reviwe. PLoS One 4 (6) (2009) e5865

206. Kersting A, Ohrmann P, Pedersen A, Kroker K, Samberg D, Bauer J, Kugel H, Koelke- beck K, Steinhard J, Heindel W, Arolt V, Suslow T: Neural activation underlying acute grief in woman after the loss of an unborn child. Am J Psychiatry 12 (2009), 1402-1410

207. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S, Kohli MA, Hennings JM, Horstmann S, Kloiber S, Menke A, Bondy B, Rupprecht R, Domschke K, Baune BT, Arolt V, Rush AJ, Holsboer F, Müller-Myhsok B: A Genomwide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in De- pression. Arch Gen Psychiatry 66 (2009), 966-975

208. Pohle K, Domschke K, Roehrs T, Arolt V, Baune BT: Medical Comorbidity Affects Anti- depressant Treatment Response in Patients with Melancholic Depression. Psychother Psychosom 78 (2009) 359-363

209. Gloster AT, Wittchen HU, Einsle F, Höfler M, Lang Tm Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW; Gerlach AL, Ströhle A, Kircher T, Deckert J, Zwanzger P, Arolt V,: Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraophobia. Eur Arch Psychiatry Clin Neurosci. 259 (2009) (Suppl 2), 155-166

210. Pyka M, Beckmann CF, Schöning S, Hauke S, Heider D, Kugel H, Arolt V, Konrad C:

Impact of working memory load on FMRI resting state pattern in subsequent resting phases. PLoS One 4 (9) (2009) e7198

211. Baune BT, Dannlowski U, Domschke K, Janssen DG, Jordan MA, Ohrmann P, Bauer J, Biros E, Arolt V, Kugel H, Baxter AG, Suslow T: The Interleukin 1 Beta (1IL1B) Gene is Associated with Failure to Achieve Remission and Impaired Emotion Processing in Major Depression. Biol Psychiat 67 (6) (2010) 543-549

212. Lucae S, Ising M, Horstmann S, Baune BT, Arolt V, Müller-Myhsok B, Holsboer F, Domschke K: HTR2A gene variation is involved in antidepressant treatment response.

Eur Neuropsychopharmacol 20 (2010), 65-68

213. Suslow T, Konrad C, Kugel H, Rumstadt D, Zwitserlood P, Schöning S, Ohrmann P, Bauer J, Pyka M, Kersting A, Arolt V, Heindel W, Dannlowski U: Automatic Mood- Congruent Amygdala Responses to Masked Facial Expressions in Major Depression.

Biological Psychiatry 67 (2010); 155-160

214. Behnken A, Schöning S, Gerß J, Konrad C, de Jong-Meyer R, Zwanzger P, Arolt V:

Persistent non-verbal memory impairment in remitted major depression – Caused by encording deficits? J Affect Dis 122 (2010) 144-148

(17)

215. Reker M, Ohrmann P, Rauch AV, Kugel H, Bauer J, Dannlowski U, Arolt V, Heindel W, Suslow T: Individual differences in alexithymia and brain response to masked emotion faces. Cortex 46 (2010), 658-667

216. Domschke K, Lawford B, Laje G, Berger K, Young R, Morris P, Deckert J, Arolt V, McMahon FJ, Baune BT: Brain-derived neurotropic factor (BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol 13 (2010) 93- 101

217. Suslow T, Kugel H, Reber H, Bauer J, Dannlowski U, Kersting A, Arolt V, Heindel W, Ohrmann P, Egloff B: Automatic brain response to facial emotions as a function on im- plicitly and explicitly measured extraversion. Neuroscience 167 (2010), 111-123

218. Schöning S, Engelien A, Bauer C, Kugel H, Kersting A, Roestel C, Zwitsserlood P, Pyka M, Dannlowski U, Lehmann W, Heindel W, Arolt V, Konrad C: Neuroimaging Dif- ferences in Spatial Cognition between Men and Male-to-Female Transsexualismus Be- fore and During Hormone Therapy. J Sex Med 7 (5) (2010), 1858-1867

219. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, Kugel H, Zwanzger P, Heindel W, Deckert J, Arolt V, Suslow T, Baune BT: Neuropeptide Y (NPY) gene: Im- pact on emotional processing and treatment response anxious depression. Eur Neuro- psychopharmcol 20 (2010) 301-309

220. Koelkebeck K, Pedersen A, Suslow T, Kueppers KA, Arolt V, Ohrmann P: Theory of Mind in first-episode schizophrenia patients: Correlations with cognition and personality traits. Schiz Res 119 (2010) 115-123

221. Dannlowski U, Konrad , Kugel H, Zwitserlood P, Domschke K, Schöning S, Ohrmann P, Bauer J, Pyka M, Hohoff C, Zhang W, Baune BT, Heindel W, Arolt V, Suslow T:

Emotion specific modulation of automatic amygdale responses by 5-HTTLPR genotype. Neuroimage 53 (3) (2010), 893-898

222. Zwanzger P, Arolt V: Persistent depressive mood and residual symptoms after depression. Often inconspicuous but still need to be treated. MMW Fortschritte Med 152 (3) (2010), 30

223. Rauch AV, Reker M, Ohrmann P, Pedersen A, Bauer J, Dannlowski U, Harding L, Koelkebeck K, Konrad C, Kugel H, Arolt V, Heindel W, Suslow T: Increased amygdale activation during automatic processing of facial emotion in schizophrenia. Psychiatry Research Neuroimaging 182 (2010) 200-206

224. Baffa A, Hohoff C, Baune BT, Müller-Tidow C, Tidow N, Freitag C, Zwanzger P, Deckert J, Arolt V, Domschke K: Norepine and Serotonin Transporter Genes: Impact on Treatment Response in Depression. Neuropsychobiologie 62 (2) (2010),121-131

225. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Ger- lach AL, Kircher T, Lang R, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen H-U, Arolt V, Pauli P, Hamm A, Deckert J: Neuropeptide S receptor gene – converging evidence for a role in panic disorder. Molecular Psychiatry (2010), 1-11

226. Pfleiderer B, Zinkirciran S, Michael N, Hohoff C, Kersting A, Arolt V, Deckert J, Dom- schke K: Altered auditory processing in patients with panic disorder: A pilot study.

World J Biol Psychiatry 11 (2010), 945-955

(18)

227. Sehlmeyer C, Konrad C, Zwitserlood P, Arolt V, Falkenstein M, Beste C: ERP indices for response inhibition are related to anxiety-related personality traits. Neuropsycholo- gia 48 (9) (2010), 2488-2495

228. Konrad C, Geburek AJ, Rist F, Blumenroth H, Fischer B, Husstedt I, Arolt V, Schiff- bauer H, Lohmann H: Long-term cognitive and emotional consequences of mild traumatic brain injury. Psychol Med 22 (2010) 1-15

229. Wilsmeier A, Ohrmann P, Suslow T, Siegmund A, Kölkebeck K, Rothermundt M, Kugel H, Arolt V, Bauer J, Pedersen A: Neural correlates of set-shifting: decomposing execu- tive functions in schizophrenia. J Psychiatry Neurosci 35 (2010) 321-329

230. Domschke K, Lawford B, Young R, Voisey J, Morris CP, Roehrs T, Hohoff C, Birosova E, Arolt V, Baune BT: Dysbindin (DTNBP1) – A role in psychotic depression ? J Psy- chiatr Res 45 (2011), 588-595

231. Sehlmeyer C, Dannlowski U, Schöning S, Kugel H, Pyka M, Pfleiderer B, Zwitserlood P, Schiffbauer H, Heindel W, Arolt V, Konrad C: Neural correlates of trait anxiety in fear extinction. Psychol Med 41 (2011) , 789-798

232. Pyka M, Burgmer M, Lenzen T, Pioch R, Dannlowski U, Pfleiderer B, Ewert AW, Heuft G, Arolt V, Konrad C: Brain correlates of hypnotic paralysis – a resistant-state FMRI study. Neuroimage 56 (2011), 2173-2182

233. Grotegerd D, Suslow T, Arolt V, Heindel W, Domschke K: Neuropeptide-S (NPS) Re- ceptor Genotype Modulates Basolateral Amygdala Responsiveness to Aversive Stimuli Dannlowski U, Kugel H, Franke F, Stuhrmann A, Hohoff C, Zwanzger P, Lenzen T,.

Neuropsychopharmacology 36 (2011), 1879-1885

234. Gloster AT, Wittchen HU, Einsle F, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Apers GW, Gerlach AL, Ströhle A, Kircher T, Zwanzger P, Höfler M, Arolt V: Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-quided exposure in situ in CBT. J Con- sult Clin Psychol 79 (2011), 406-420

235. Weber H, Kittel-Schneider S, Gessner A, Domschke K, Neuner M, Jacob CP, Butten- schon HN, Boreatti-Hümmer A, Volkert J, Herterich S, Baune BT, Gross-Lesch S, Kopf J, Kreiker S, Nguyen TT, Weissflog L, Arolt V, Mors O, Deckert J, Lesch KP, Reif A:

Cross Disorder Analysis of Bipolar Risk Genes: Further Evidence of DGKH as a Risk Gene for Bipolar Disorder, but also Unipolar Depression and Adult ADHD. Neuropsy- chopharmacology 10 (2011), 2076-2085

236. Klauke B, Deckert J, Reif A, Pauli P, Zwanzger P, Baumann C, Arolt V, Glöckner-Rist A, Domschke K: Serotonin transporter gene and childhood trauma – a G x E effect on anxiety sensitivity. Depress Anxiety (2011) im Druck

237. Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, Arolt V, Müller N: Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression – No influence of celecoxib treatment. J Affect Disord 134 (2011), 217-225

238. Domschke K, Gajewska A, Winter B, Herrmann MJ, Warrings B, Mühlberger A, Wos- nitza K, Glotzbach E, Conzelmann A, Dlugos A, Fobker M, Jakob C, Arolt V, Reif A, Pauli P, Zwanzger P, Deckert J: ADORA2A Gene Variation, Caffeine, and Emotional Processing: A Multi-level Interaction on Startle Reflex. Neuropsychopharmacology (2011) im Druck

(19)

239. Menke A, Domschke K, Czamara D, Klengel T, Hennings J, Lucae S, Baune BT, Arolt V, Müller-Myhsok B, Holsboer F, Binder EB: Genome-Wide Association Study of Anti- depressant Treatment-Emergent Suicidal Ideation. Neuropsychopharmacology (2011) im Druck